We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$28.8B
AUM Growth
-$783M
Cap. Flow
-$2.41B
Cap. Flow %
-8.37%
Top 10 Hldgs %
9.51%
Holding
1,466
New
69
Increased
389
Reduced
586
Closed
155

Top Buys

Rank Stock Value
1
AXE
Anixter International Inc
AXE
+$64.8M
2
APAM icon
Artisan Partners
APAM
+$56.9M
3
DORM icon
Dorman Products
DORM
+$52.1M
4
RES icon
RPC Inc
RES
+$46.1M
5
NUS icon
Nu Skin
NUS
+$42.4M

Sector Composition

Rank Sector Weight
1 Industrials 26.03%
2 Technology 18.79%
3 Consumer Discretionary 15.93%
4 Financials 10.69%
5 Materials 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRC icon
1126
NRC Health Common Stock
NRC
$490M
$560K ﹤0.01%
40,033
OESX icon
1127
Orion Energy Systems
OESX
$113M
$550K ﹤0.01%
10,000
XWES
1128
DELISTED
WORLD ENERGY SOLUTIONS INC NEW COMMON (DE)
XWES
$550K ﹤0.01%
100,000
IMNN icon
1129
Imunon
IMNN
$8.08M
$543K ﹤0.01%
85
NTRI
1130
DELISTED
NutriSystem, Inc.
NTRI
$541K ﹤0.01%
27,660
+5,600
+25% +$99.5K
MRH
1131
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
$522K ﹤0.01%
14,576
-301,991
-95% -$10.1M
SZYM
1132
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$508K ﹤0.01%
196,718
-687,447
-78% -$3.01M
REN
1133
DELISTED
Resolute Energy Corporaton
REN
$495K ﹤0.01%
75,047
RIGL icon
1134
Rigel Pharmaceuticals
RIGL
$862M
$489K ﹤0.01%
21,539
CVEO icon
1135
Civeo
CVEO
$348M
$484K ﹤0.01%
9,817
-4,683
-32% -$583K
CCXI
1136
DELISTED
ChemoCentryx, Inc.
CCXI
$478K ﹤0.01%
70,000
PTEN icon
1137
Patterson-UTI
PTEN
$4.91B
$476K ﹤0.01%
28,665
-767,509
-96% -$16.2M
CCBG icon
1138
Capital City Bank Group
CCBG
$865M
$463K ﹤0.01%
29,822
IA
1139
Innovative Solutions & Support
IA
$324M
$454K ﹤0.01%
142,828
BSQR
1140
DELISTED
BSQUARE Corporation
BSQR
$449K ﹤0.01%
98,675
-95,200
-49% -$386K
LOV
1141
DELISTED
Spark Networks SE American Depositary Shares
LOV
$440K ﹤0.01%
122,500
+22,800
+23% +$91.2K
MCHX icon
1142
Marchex
MCHX
$52.3M
$436K ﹤0.01%
95,000
PCTI
1143
DELISTED
PCTEL, Inc. Common Stock
PCTI
$436K ﹤0.01%
50,400
ASTC icon
1144
Astrotech Corp
ASTC
$13.5M
$432K ﹤0.01%
+1,167
New +$446K
SIMO icon
1145
Silicon Motion
SIMO
$8.06B
$430K ﹤0.01%
18,200
-23,600
-56% -$566K
LODE icon
1146
Comstock
LODE
$198M
$429K ﹤0.01%
2,260
+760
+51% +$202K
MCP
1147
DELISTED
MOLYCORP INC COM STK
MCP
$423K ﹤0.01%
480,511
-607,989
-56% -$698K
TACT icon
1148
Transact Technologies
TACT
$52.6M
$422K ﹤0.01%
78,600
MSCI icon
1149
MSCI
MSCI
$39.9B
$413K ﹤0.01%
8,700
LOGI icon
1150
Logitech
LOGI
$14.5B
$406K ﹤0.01%
30,200
+600
+2% +$8.21K

Similar funds

Royce & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Royce & Associates held 1,466 positions worth $28.8B, down 2.6% from $29.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates withdrew a net $2.41B in Q4 2014, closing 155 positions and reducing 586 holdings. Its most notable exit was Strategic Education, an estimated $42.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Avid Technology Inc worth $27.2M.

  • Royce & Associates's largest Q4 2014 buy was Avid Technology Inc: 1,911,784 shares worth $27.2M.
  • Royce & Associates added most to Anixter International Inc in Q4 2014, an estimated $64.8M increase.
  • Royce & Associates's biggest Q4 2014 reduction was Myriad Genetics, cutting an estimated $136M.
  • Royce & Associates fully exited Strategic Education in Q4 2014, selling an estimated $42.5M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $28.8B portfolio in Q4 2014.
  • Royce & Associates opened 69 new positions and closed 155 in Q4 2014.
  • Royce & Associates's portfolio value fell 2.6% quarter-over-quarter to $28.8B.

Based on Royce & Associates's 13F filing for Q4 2014, filed 9 Feb 2015.